These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6105376)

  • 21. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine and Huntington's chorea.
    Frattola L; Albizzatir MG; Trabucchi M
    Arch Neurol; 1978 Jan; 35(1):60. PubMed ID: 145841
    [No Abstract]   [Full Text] [Related]  

  • 23. Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.
    Gonzalez V; Cif L; Biolsi B; Garcia-Ptacek S; Seychelles A; Sanrey E; Descours I; Coubes C; de Moura AM; Corlobe A; James S; Roujeau T; Coubes P
    J Neurosurg; 2014 Jul; 121(1):114-22. PubMed ID: 24702329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Huntington's chorea. A random process.
    Tan BK; Mastebroek HA; Zaagman WH
    Clin Neurol Neurosurg; 1976; 79(3):215-21. PubMed ID: 141992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 27. Involuntary movements in chorea-acanthocytosis: a comparison with Huntington's chorea.
    Shibasaki H; Sakai T; Nishimura H; Sato Y; Goto I; Kuroiwa Y
    Ann Neurol; 1982 Sep; 12(3):311-4. PubMed ID: 6215892
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma choline and cholinergic mechanisms in the brain. Methods, function, and rôle in Huntington's chorea.
    Eckernäs SA
    Acta Physiol Scand Suppl; 1977; 449():1-62. PubMed ID: 143869
    [No Abstract]   [Full Text] [Related]  

  • 29. Apomorphine in Huntington's chorea: clinical observations and theoretical considerations.
    Tolosa ES; Sparber SB
    Life Sci; 1974 Oct; 15(7):1371-80. PubMed ID: 4283614
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacology of Huntington's chorea. Personal experience.
    Caraceni T; Giovannini P; Girotti F; Avanzini G
    Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
    Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ
    Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Huntington's disease].
    Pogledić I; Relja M
    Lijec Vjesn; 2012; 134(11-12):346-50. PubMed ID: 23401981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease.
    Tedroff J; Ekesbo A; Sonesson C; Waters N; Carlsson A
    Neurology; 1999 Oct; 53(7):1605-6. PubMed ID: 10534281
    [No Abstract]   [Full Text] [Related]  

  • 35. Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
    Piolti R; Appollonio I; Perego M; Pozzi C; Rovati L; Ferrarese C; Frattola L
    Eur Neurol; 1995; 35(6):344-8. PubMed ID: 8591802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The electromyographic silent period in Huntington's chorea--a comparison between childhood and adult values.
    Sandyk R
    S Afr Med J; 1982 Feb; 61(9):316-7. PubMed ID: 6460326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
    Reuter I; Hu MT; Andrews TC; Brooks DJ; Clough C; Chaudhuri KR
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):238-41. PubMed ID: 10644798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value?
    Tremolizzo L; Rodriguez-Menendez V; DiFrancesco JC; Sala G; Galbussera A; Appollonio I; Ferrarese C
    Med Hypotheses; 2007; 69(4):964-5. PubMed ID: 17428619
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluoxetine-induced exacerbation of chorea in Huntington's disease? A case report.
    Chari S; Quraishi SH; Jainer AK
    Pharmacopsychiatry; 2003 Jan; 36(1):41-3. PubMed ID: 12649776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.